Results
1 -
10 of
23
(Click
here to explore results)
- Ultra pH-sensitive polymeric nanovesicles co-deliver doxorubicin and navitoclax for synergetic therapy of endometrial carcinoma. Jie Ding, Xu Zhang, Chuangqi Chen, Yuqiang Huang, Xingsu Yu, Xiaomao Li
, Biomater. Sci.
, 2020
, 8
, 2264
- Chemogenomics for drug discovery: clinical molecules from open access chemical probes. Robert B. A. Quinlan, Paul E. Brennan
, RSC Chem. Biol.
, 2021
, 2
, 759
- Analysis of physicochemical properties of protein–protein interaction modulators suggests stronger alignment with the “rule of five”. Jia Truong, Ashwin George, Jessica K. Holien
, RSC Med. Chem.
, 2021
, 12
, 1731
- Glycosidase activated prodrugs for targeted cancer therapy. Harlei Martin, Laura Ramírez Lázaro, Thorfinnur Gunnlaugsson, Eoin M. Scanlan
, Chem. Soc. Rev.
, 2022
, 51
, 9694
- Identification of novel Src, Bcl-2 dual inhibitors by the pharmacophore model, molecular docking, and molecular dynamics simulations. Li-chuan Zhang, Hao-ran Zhang, Cheng-long Gao, Ri-lei Yu, Cong-min Kang
, New J. Chem.
, 2021
, 45
, 14063
- The era of high-quality chemical probes. Marco P. Licciardello, Paul Workman
, RSC Med. Chem.
, 2022
, 13
, 1446
- A regioselective synthesis of poly-substituted aryl triflones through self-promoting three component reaction. Hikaru Yanai, Masaya Fujita, Takeo Taguchi
, Chem. Commun.
, 2011
, 47
, 7245
- Small molecules targeting Mcl-1: the search for a silver bullet in cancer therapy. Duong Nhu, Guillaume Lessene, David C. S. Huang, Christopher J. Burns
, Med. Chem. Commun.
, 2016
, 7
, 778
- Rational design and structure–activity relationship studies of quercetin–amino acid hybrids targeting the anti-apoptotic protein Bcl-xL. Tahsin F. Kellici, Maria V. Chatziathanasiadou, Min-Sung Lee, Nisar Sayyad, Elena G. Geromichalou, Eirinaios I. Vrettos, Antonis D. Tsiailanis, Seung-Wook Chi, George D. Geromichalos, Thomas Mavromoustakos, Andreas G. Tzakos
, Org. Biomol. Chem.
, 2017
, 15
, 7956
- Structural revision of the Mcl-1 inhibitor MIM1: synthesis and biological studies on ovarian cancer cells with evaluation of designed analogues. Hippolyte Paysant, Siham Hedir, Frédéric Justaud, Louis Bastien Weiswald, Assaad Nasr El Dine, Ali Soulieman, Ali Hachem, Nicolas Elie, Emilie Brotin, Christophe Denoyelle, Jérôme Bignon, Fanny Roussi, Marie Jouanne, Olivier Tasseau, Thierry Roisnel, Anne Sophie Voisin-Chiret, René Grée, Nicolas Levoin, Laurent Poulain
, Org. Biomol. Chem.
, 2021
, 19
, 8968